Patrick Wood Analyst Performance

Managing Director at Morgan Stanley

Patrick Wood is a stock analyst at Morgan Stanley in the medical sector, covering 19 publicly traded companies. Over the past year, Patrick Wood has issued 31 stock ratings, including buy, hold, and sell recommendations. While full access to Patrick Wood's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Patrick Wood's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rating: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 32 Last 7 Years
Buy Recommendations: 40.63% 13 Buy Ratings
Companies Covered: 19 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	40.6%	13 ratings
Hold	50.0%	16 ratings
Sell	9.4%	3 ratings

Out of 32 total stock ratings issued by Patrick Wood at Morgan Stanley, the majority (50.0%) have been Hold recommendations, followed by 40.6% Buy and 9.4% Sell.

Best & Worst Calls

Best Call
000.0%
DVA
Dec 2017
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NYSE	57.9% of companies on NYSE	11 companies
NASDAQ	42.1% of companies on NASDAQ	8 companies

Patrick Wood, an analyst at Morgan Stanley, currently covers 19 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 19 companies	100.0%

Patrick Wood of Morgan Stanley specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED INSTRUMENTS 10 companies	52.6%
MEDICAL SERVICES 3 companies	15.8%
MED PRODUCTS 3 companies	15.8%
MED/DENTAL - SUPP 2 companies	10.5%
MED - OUTP/HM CRE 1 company	5.3%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
COO Cooper Companies	8/28/2025	Set Price Target	$64.86	$76.00	Equal Weight
ALC Alcon	8/21/2025	Lower Price Target	$78.90	$80.00	Equal Weight
BDX Becton, Dickinson and Company	8/11/2025	Boost Price Target	$190.78	$197.00	Overweight
NTRA Natera	8/10/2025	Reiterated Rating	$151.95	$195.00	Overweight
STE STERIS	8/8/2025	Boost Price Target	$241.45	$295.00	Overweight
BLCO Bausch + Lomb	8/1/2025	Boost Price Target	$13.36	$13.00	Equal Weight
TMDX TransMedics Group	8/1/2025	Boost Price Target	$121.15	$123.00	Equal Weight
GEHC GE HealthCare Technologies	7/31/2025	Lower Price Target	$71.70	$74.00	Equal Weight
EW Edwards Lifesciences	7/15/2025	Boost Price Target	$78.35	$81.00	Equal Weight
DXCM DexCom	7/15/2025	Boost Price Target	$85.33	$89.00	Equal Weight
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
BAX Baxter International	7/15/2025	Lower Price Target	$28.53	$27.00	Underweight
ALC Alcon	7/15/2025	Lower Price Target	$87.36	$84.00	Equal Weight
PRCT PROCEPT BioRobotics	7/15/2025	Lower Price Target	$56.25	$68.00	Overweight
SOLV Solventum	7/15/2025	Upgrade	$74.08	$103.00	Overweight
STE STERIS	7/15/2025	Upgrade	$225.61	$276.00	Overweight
RXST RxSight	7/15/2025	Downgrade	$7.74	$9.00	Equal Weight
STE STERIS	5/19/2025	Boost Price Target	$252.45	$260.00	Equal Weight
BSX Boston Scientific	5/16/2025	Boost Price Target	$105.41	$125.00	Overweight
BLCO Bausch + Lomb	5/6/2025	Lower Price Target	$11.34	$12.00	Equal Weight
BDX Becton, Dickinson and Company	5/6/2025	Lower Price Target	$165.80	$196.00	Overweight
GKOS Glaukos	5/6/2025	Lower Price Target	$85.76	$72.00	Underweight
GEHC GE HealthCare Technologies	5/6/2025	Lower Price Target	$68.40	$78.00	Equal Weight
BAX Baxter International	5/5/2025	Lower Price Target	$30.58	$28.00	Underweight
TFX Teleflex	5/5/2025	Lower Price Target	$125.46	$173.00	Overweight
TNDM Tandem Diabetes Care	3/5/2025	Downgrade	$19.49	$22.00	Equal Weight
TFX Teleflex	3/5/2025	Lower Price Target	$130.87	$191.00	Overweight
SOLV Solventum	3/5/2025	Boost Price Target	$78.99	$80.00	Equal Weight
PRCT PROCEPT BioRobotics	2/26/2025	Lower Price Target	$65.94	$95.00	Overweight
DXCM DexCom	2/14/2025	Boost Price Target	$84.09	$82.00	Equal Weight
EW Edwards Lifesciences	2/12/2025	Boost Price Target	$70.95	$75.00	Equal Weight
BSX Boston Scientific	2/6/2025	Boost Price Target	$104.95	$120.00	Overweight

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.